Alex Welte
Alex Welte
Adresse e-mail validée de
Citée par
Citée par
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
R Kassanjee, CD Pilcher, SM Keating, SN Facente, E McKinney, MA Price, ...
AIDS (London, England) 28 (16), 2439, 2014
Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation
MP Busch, CD Pilcher, TD Mastro, J Kaldor, G Vercauteren, W Rodriguez, ...
Aids 24 (18), 2763-2771, 2010
Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward
TD Mastro, AA Kim, T Hallett, T Rehle, A Welte, O Laeyendecker, ...
Journal of HIV AIDS surveillance & epidemiology 2 (1), 1, 2010
HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing
T Bärnighausen, C Wallrauch, A Welte, TA McWalter, N Mbizana, ...
PLoS One 3 (11), e3640, 2008
A new general biomarker-based incidence estimator
R Kassanjee, TA McWalter, T Bärnighausen, A Welte
Epidemiology (Cambridge, Mass.) 23 (5), 721, 2012
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy
ET Marinda, J Hargrove, W Preiser, H Slabbert, G Van Zyl, J Levin, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (4), 496-499, 2010
Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes
YT Duong, R Kassanjee, A Welte, M Morgan, A De, T Dobbs, ...
PloS one 10 (2), e0114947, 2015
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
Viral load criteria and threshold optimization to improve HIV incidence assay characteristics-a CEPHIA analysis
R Kassanjee, CD Pilcher, MP Busch, G Murphy, SN Facente, SM Keating, ...
AIDS (London, England) 30 (15), 2361, 2016
Tuberculosis in a South African prison–a transmission modelling analysis
SJ Robertson, SD Lawn, A Welte, LG Bekker, R Wood
South African Medical Journal 101 (11), 809-813, 2011
Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?
C Hankins, J Hargrove, B Williams, L Abu Raddad, B Auvert, L Bollinger, ...
More and better information to tackle HIV epidemics: towards improved HIV incidence assays
Incidence Assay Critical Path Working Group
PLoS medicine 8 (6), e1001045, 2011
Evaluating audio computer assisted self-interviews in urban south African communities: evidence for good suitability and reduced social desirability bias of a cross-sectional …
R Beauclair, F Meng, N Deprez, M Temmerman, A Welte, N Hens, ...
BMC medical research methodology 13, 1-7, 2013
Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models
D Keebler, P Revill, S Braithwaite, A Phillips, N Blaser, A Borquez, ...
The Lancet Global Health 2 (1), e35-e43, 2014
HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis
T Bärnighausen, TA McWalter, Z Rosner, ML Newell, A Welte
Epidemiology, 685-697, 2010
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.
W Sykes, L Mhlanga, R Swanevelder, TN Glatt, E Grebe, C Coleman, ...
Research Square, 2021
Relating recent infection prevalence to incidence with a sub-population of assay non-progressors
TA McWalter, A Welte
Journal of mathematical biology 60, 687-710, 2010
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation
W Delva, DP Wilson, L Abu-Raddad, M Gorgens, D Wilson, TB Hallett, ...
PLoS Medicine 9 (7), e1001239, 2012
Treatment as prevention: preparing the way
B Williams, R Wood, V Dukay, W Delva, D Ginsburg, J Hargrove, ...
Journal of the International AIDS Society 14 (1), 1-6, 2011
HIV antibody level as a marker of HIV persistence and low-level viral replication
SM Keating, CD Pilcher, V Jain, M Lebedeva, D Hampton, ...
The Journal of infectious diseases 216 (1), 72-81, 2017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20